Anil Singhal, Ph.D.
Board Member
Werewolf Therapeutics, Inc. (HOWL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Anil Singhal, Ph.D.
Anil Singhal, Ph.D. is recorded as Board Member at Werewolf Therapeutics, Inc. (HOWL). Werewolf Therapeutics, Inc. reported in an 8-K filed February 24, 2025 that Anil Singhal, Ph.D. was appointed Class I director, effective February 19, 2025.
“On February 19, 2025, the Board of the Company, upon recommendation of the Board's Nominating and Corporate Governance Committee, appointed Anil Singhal, Ph.D., as a director.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-02-19–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Werewolf Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Daniel J. Hicklin CEO, Board Member
- Michael Urban CFO
- Reid Leonard COO
- Chulani Karunatilake CTO
- Meeta Chatterjee, Ph.D. Board Member
- Michael A. Sherman Board Member
- Michael B. Atkins Board Member
- Michael B. Atkins, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.